假设:HPV E6和COVID尖端蛋白在向p53的瘤抑制方面进行合作
Wafik S El-Deiry1,2,3,4,5
1Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Warren Alpert Medical School, Brown University, Providence, RI 02912, USA.
Oncotarget
|January 7, 2026
概括
人类乳头瘤病毒 (HPV) 和SARS-COV-2尖端蛋白可能抑制瘤抑制剂p53,可能增加癌症风险. 需要进一步的研究来探索病毒蛋白和癌症发展之间的这种联系.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- 人类乳头瘤病毒 (HPV) 是已知的各种癌症的原因,包括宫癌,头癌和门癌.
- HPV的E6蛋白针对瘤抑制剂p53进行降解,促进癌症的发展.
- 该假设认为,SARS-COV-2和HPV一样,可能与癌症的发展有关.
研究的目的:
- 提出一种假设,病毒编码的蛋白质,如HPV-E6和SARS-COV-2 Spike,可能在抑制宿主防御方面进行合作.
- 探索这些病毒蛋白在抑制瘤抑制机制方面的潜在作用,特别是涉及p53.
- 建议进一步调查病毒感染,疫苗接种和癌症之间的关系.
主要方法:
- 审查有关HPV,SARS-COV-2和癌症的现有文献.
- 分析病毒蛋白 (HPV-E6,SARS-COV-2 Spike) 可能影响p53功能的拟议机制.
- 考虑有关mRNA疫苗和癌症复发之间的事和初步证据.
主要成果:
- 该假设表明,HPV-E6和SARS-COV-2两种尖端蛋白都可能抑制p53功能.
- 有证据表明mRNA疫苗 (产生Spike蛋白) 与癌症发展或复发之间存在潜在联系.
- 一项案例研究表明,HPV相关的癌症,COVID-19 mRNA疫苗接种和瘤进展之间可能存在相互作用.
结论:
- 像HPV-E6和SARS-COV-2 Spike这样的病毒编码蛋白可能一起破坏宿主防御,包括p53介导的瘤抑制.
- 这一假设需要通过流行病学和实验室研究进一步调查.
- 了解这些相互作用可能对癌症预防和治疗策略产生重大影响.
相关概念视频
02:23Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
01:51Mechanisms of Retrovirus-induced Cancers
6.8K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.8K
01:19Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
01:23Negative Regulator Molecules
38.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.2K
01:03Rous Sarcoma Virus (RSV) and Cancer
6.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.2K
02:34Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K